Tržní kapitalizace společnosti Midatech Pharma Plc
Jaká je hodnota metriky Tržní kapitalizace společnosti Midatech Pharma Plc?
Hodnota metriky Tržní kapitalizace společnosti Midatech Pharma Plc je $1.63M
Jaká je definice metriky Tržní kapitalizace?
Tržní kapitalizace (Market cap) je tržní hodnotou vydaných akcií obchodované společnosti a rovná se ceně akcií v daném čase vynásobené počtem kusů vydaných akcií .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Tržní kapitalizace společností v sektoru Health Care sektor na LSE ve srovnání se společností Midatech Pharma Plc
Čemu se věnuje společnost Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Firmy s metrikou tržní kapitalizace podobnou společnosti Midatech Pharma Plc
- Hodnota metriky Tržní kapitalizace společnosti Kisses from Italy je $1.63M
- Hodnota metriky Tržní kapitalizace společnosti ADM plc je $1.63M
- Hodnota metriky Tržní kapitalizace společnosti Killi je $1.63M
- Hodnota metriky Tržní kapitalizace společnosti ArcPacific Resources je $1.63M
- Hodnota metriky Tržní kapitalizace společnosti Westcore je $1.63M
- Hodnota metriky Tržní kapitalizace společnosti SNP Schneider-Neureither & Partner SE je $1.63M
- Hodnota metriky Tržní kapitalizace společnosti Midatech Pharma Plc je $1.63M
- Hodnota metriky Tržní kapitalizace společnosti Therapix Biosciences je $1.63M
- Hodnota metriky Tržní kapitalizace společnosti Enea AB (publ) je $1.64M
- Hodnota metriky Tržní kapitalizace společnosti VIP Gloves je $1.64M
- Hodnota metriky Tržní kapitalizace společnosti Aphelion Capital je $1.64M
- Hodnota metriky Tržní kapitalizace společnosti CE Brands je $1.64M
- Hodnota metriky Tržní kapitalizace společnosti Sky Gold je $1.64M